United States · FDA National Drug Code directory
perphenazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-591_520360a9-ddcd-46f4-995b-d776c5b2937c
- Product NDC
- 68382-591
- Form
- TABLET
- Composition / generic term
- perphenazine
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200716
- Source listing expiry
- 20261231
Source-listed ingredients
- PERPHENAZINE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-591-01) · 68382-591-01
- 500 TABLET in 1 BOTTLE (68382-591-05) · 68382-591-05
- 10 BLISTER PACK in 1 CARTON (68382-591-30) / 10 TABLET in 1 BLISTER PACK · 68382-591-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →